1997 -1999 Senior Director, Technology Prospecting @ Monsanto Company
1990 -1997 Senior Group Leader, Immune and Inflammatory Disease Research @ G.D. Searle, a Monsanto Company
Susan Gregory Education
Southern Illinois University, Carbondale
Ph.D.
1979-1983
University of Illinois Urbana-Champaign
B.S.
1973-1977
University of Illinois Urbana-Champaign
Bachelor of Science - BS
Southern Illinois University, Carbondale
Susan Gregory Skills
Program Planning
Communication
Board of Directors
Clinical Research
Drug Development
Strategic Alliances
Pharmaceutical Industry
Oncology
Clinical Trials
GLP
Pharmaceutics
Technology Transfer
Regulatory Submissions
Research
Good Laboratory Practice (GLP)
Clinical
Pharmaceuticals
Pharmaceutical Development
Life Sciences
Venture Capital
Good Manufacturing Practice (GMP)
Integration
U.S. Food and Drug Administration (FDA)
Consulting
Due Diligence
Toxicology
IND
Inflammation
Biomarkers
Biomarker Discovery
Lead Optimization
Autoimmune Diseases
Ion Channels
New Drug Application (NDA)
Global Drug Development
Allergy
In Vivo
Co-development
Project Planning
Drug Discovery
Pharmacology
Clinical Development
Immunology
Biotechnology
Pharmaceutical
Good Laboratory Practice Glp
Co Development
Good Manufacturing Practice Gmp
U.S. Food And Drug Administration Fda
New Drug Application Nda
Good Laboratory Practice
Good Manufacturing Practice
u.s. Food and Drug Administration
New Drug Application
Susan Gregory Summary
Susan Gregory, based in Glenview, IL, US, is currently a Nonprofit Board Director and Member, Social Justice Advocate at Me. Susan Gregory brings experience from previous roles at SA Gregory Associates, LLC, Takeda Pharmaceuticals and The Gregory Group. Susan Gregory holds a 1979 - 1983 Ph.D. @ Southern Illinois University, Carbondale. With a robust skill set that includes Program Planning, Communication, Board of Directors, Clinical Research, Drug Development and more. Susan Gregory has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Susan Gregory?
Find contact details for 700 million professionals.